Well..... What can I really do about this 1 but I guess wait??? Its a stock that I think looks good. Also a idea I put back in place to see if the trade will work. Volume hasn't been there so much today but overall, over a good amount long term. PLEASE TRADE SAFE. #InvestSmart
ECOR, will drop a bit tomorrow, so don't buy at OPEN. Then it should RISE to 2.30 then bounce up even more. Wait 15-20 minutes after open to buy then i recommend you rider RIDE the wave. Buy at support, Sell at Resistance. That's one way. Second way is to split your profits into 1/3 for morning, afterlunch and closing. Good Luck!
electroCore Announces FDA Emergency Use Authorization for use of gammaCore Sapphire™ CV for the Acute Treatment of Asthma Exacerbations in Known or Suspected COVID-19 Patients. investor.electrocore.com www.marketwatch.com
This video is pretty long. Its a RISKY play I think I'm doing but a HEALTHY one if I get its reward... I'm thinking a SWING trade for a little bit and see if I end up in NO MANS LAND! #InvestSmart #TradeSafe NASDAQ:ECOR
electroCore shares are trading higher after the director bought roughly 1.765 million shares at a price of $0.85 per share.
On monday watch as COVID-19 stock , pure day tarde ,
Buy ECOR ON ROBINHOOD OR WEBULL ENTRY 1 1.34 ENTRY 2 0.86 Tp.1 $3.00 Tp.2 $5.00 TP.3 $ 7.50
$ECOR Daily Timeframe / Not a big fan of the upper wick on the current daily candle but I would like to see price action test 3.00 again.
electroCore, Inc. is a commercial-stage bio-electronic medicine company, with a platform non-invasive vagus nerve stimulation therapy focuses on neurology and rheumatology. The company's therapy, gammaCore, has pharmacologic effects on the peripheral and central nervous systems, which modulate neurotransmitters and immune function. It focuses on acute treatment of...
******UP PRE MARKET 15% BUT THIS COULD RUN A LOT HIGHER ON THE COMPANIES ANNOUNCEMENT OF RESTRUCTURING AND COST CUTTING, EXTREME RELIEF FOR INVESTORS WHOM WANTED A PRO ACTIVE APPROACH MUCH SOONER. ***** AVERAGE PRICE TARGET $20.50 AVERAGE RECOMMENDATION BUY COMPANY PROFILE electroCore, Inc. is a commercial-stage bio-electronic medicine company, with a platform...